Boston Scientific · 1 month ago
Senior Sales Operations Analyst, LAAC (WATCHMAN)
Boston Scientific is a leader in medical science dedicated to solving health industry challenges. They are seeking a Senior Sales Operations Analyst to support the LAAC (WATCHMAN) Sales Operations team by providing analytical insights and improving operational processes.
Health CareMedicalMedical Device
Responsibilities
Collaborate and partner directly with the Field Sales Organization on business planning and analytics
Provide timely, accurate, and actionable business insights to support the field sales team
Complete ad-hoc reporting and analysis requests for Field Sales, Sales Operations, and cross-functional partners
Develop and maintain reports and dashboards to deliver meaningful insights, including trend analysis, new product launch tracking, and forecast modeling, often leveraging multiple data sources
Identify and lead initiatives to improve processes and enhance efficiency
Execute, document, and maintain various Sales Operations and Program processes as required
Partner on special projects to drive organizational priorities
Actively participate in team initiatives and foster a positive, inclusive team culture
Qualification
Required
Bachelor's degree
Minimum of 3 years' experience in a sales operations, analytics, or business support role
Strong analytical and problem-solving skills with a data-driven mindset
Proficiency in Excel and Tableau, with experience using Salesforce and database management tools
Excellent oral and written communication skills with the ability to influence and collaborate effectively across teams
Demonstrated ability to balance multiple priorities and meet deadlines with accuracy and attention to detail
Strong interpersonal skills and a team-oriented approach, with the ability to work both independently and collaboratively
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2025-12-25
2025-12-12
2025-12-11
Company data provided by crunchbase